Human haemoglobin - Sangart

Drug Profile

Human haemoglobin - Sangart

Alternative Names: Hemospan; MalPEG-Hb; MP4; MP4OX; MP4OX (oxygen-carrying colloid and plasma expander); Oxygenated polyethylene glycol-modified haemoglobin; Pegylated haemoglobin-based colloid - Sangart

Latest Information Update: 19 Nov 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sangart
  • Class Haemoglobins; Plasma expanders
  • Mechanism of Action Oxygen carriers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Ischaemia

Most Recent Events

  • 19 Nov 2013 No development reported - Phase-II for Ischaemia in Australia (IV)
  • 19 Nov 2013 No development reported - Phase-II for Ischaemia in Austria (IV)
  • 19 Nov 2013 No development reported - Phase-II for Ischaemia in Brazil (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top